辽宁天安生物制药

Liaoning Tian'an Biological Pharmaceutical is a specialized biopharmaceutical manufacturer based in Benxi, China, focusing on the production of insulin products for diabetes management. The company operates as a core subsidiary of Tonghua Dongbao Pharmaceutical, one of China's leading insulin providers. Its primary operations include the large-scale production of recombinant human insulin APIs and finished dosage forms, as well as advanced insulin analogs like glargine and aspart. The facility is a key component of the Benxi High-tech Industrial Zone, utilizing high-tech fermentation and purification processes. Through its parent company's distribution network, Liaoning Tian'an provides critical glycemic control therapies to patients across China and international markets. The company maintains rigorous GMP standards to ensure the quality and safety of its biological products.